Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
OPEN International journal of antimicrobial agents | 25 Mar 2020
P Gautret, JC Lagier, P Parola, VT Hoang, L Meddeb, M Mailhe, B Doudier, J Courjon, V Giordanengo, VE Vieira, HT Dupont, S Honoré, P Colson, E Chabrière, B La Scola, JM Rolain, P Brouqui and D Raoult
Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads.
* Data courtesy of Altmetric.com